Analysis uncovers distinct epigenomic regulation and cell states in different brain regions of Alzheimer's patients, highlighting potential therapeutic targets.
Key Points
Alzheimer's disease shows significant region-specific epigenomic changes, including DNA methylation alterations and 3D genome reorganization.
Over 230,000 single cells were analyzed, revealing unique epigenomic dysregulation in temporal cortex compared to visual and prefrontal cortex.
The study utilized a large-scale, single-cell multi-omic methodology integrating DNA methylation with genome architecture analysis.
These findings suggest new avenues for therapeutic strategies targeting specific brain regions affected by AD.